We are live on ! Find out more
SVNT

SAVIENT PHARMACEUTICALS INC
SVNT

Delisted

SVNT was delisted on the 16th of October, 2013.

Back to rankings

2 hedge funds and large institutions have $1K invested in SAVIENT PHARMACEUTICALS INC in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 1 → 2 (+1)

Holders
2
Holders Change
+1
Holders Change %
+100%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
QAM
QCI Asset Management
New York
+$1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
QAM
1
QCI Asset Management
New York
$1K +$1K +500 New

SVNT Hedge Fund Activity: Q3 2019 in Review

2 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in SAVIENT PHARMACEUTICALS INC (SVNT) for Q3 2019, worth a combined $1K.

Buyers outnumbered sellers: 1 fund opened new SVNT positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was QCI Asset Management, opening a new position worth an estimated $1K.

  • 2 institutional investors held SAVIENT PHARMACEUTICALS INC (SVNT) as of Q3 2019, up from 1 in Q2 2019.
  • Funds reported $1K of SAVIENT PHARMACEUTICALS INC stock for Q3 2019.
  • 1 fund opened new SAVIENT PHARMACEUTICALS INC positions in Q3 2019 and 0 closed out, a net change of +1 holder.
  • The largest SAVIENT PHARMACEUTICALS INC buyer in Q3 2019 was QCI Asset Management, an estimated $1K added.

Based on aggregated 13F filings for Q3 2019.